ALVOW

Investor Moves

Name	Value	Action	Change	Price	Current Price
Howard MarksOaktree Capital $7.1M4.7M shares TrimQ3 2025 $1.1M $1.52 $0.18

News

seekingalpha.comAlvotech (ALVO) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 7

defenseworld.netAlvotech (NASDAQ:ALVOW) Sees Significant Decrease in Short Interestdefenseworld.netMar 28

Trade ALVOW

About Alvotech

Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.

CEO: Lisa Graver
IPO Date: Jun 16, 2022

Market Data

Open: $1.52
High: $1.52
Low: $0.1825
Volume: 9K
52W High: $1.52
52W Low: $0.1825

Valuation

Market Cap: $57M
Enterprise Value: $2.5B

Financials

Free Cash Flow: $-115M
Revenue: $586M
Net Income: $28M
Cash: $172M
Debt: $1.4B

Events

EarningsAug 19

EPS est. -0.024